Home › Funds › Soleus Capital Management, L.P. › EOLS

Soleus Capital Management, L.P. position in EOLS

EVOLUS INC · Health Care

Soleus Capital Management, L.P. reported holding 5,090,000 shares of EOLS (EVOLUS INC) in its Q3 2026 13F filing — a position valued at US$40.7M, representing 1.45% of its reported portfolio and ranking #18 among its reported holdings. Soleus Capital Management, L.P. has disclosed EOLS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.09M sh
Reported value held$40.72M
Portfolio Weight1.45%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s EOLS position evolved

Soleus Capital Management, L.P. first disclosed a stake in EOLS in Q3 2023 at 2,078,000 shares (US$19.0M). The position peaked in Q3 2026 at 5,090,000 shares, worth US$40.7M. Across 12 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,090,000 shares valued at US$40.7M — an increase of 4,267,572 shares quarter over quarter.. Notable position changes include a 620% increase in Q2 2024 (shares rose 49% over the following quarter), a 110% increase in Q1 2026 (shares rose 69% over the following quarter), a 519% increase in Q3 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.08M $18.99M New
Q1 2024 160.00K $2.24M New
Q2 2024 1.15M $12.50M Add
Q3 2024 1.04M $16.81M Reduce
Q4 2024 697.16K $7.70M Reduce
Q1 2025 1.08M $12.98M Add
Q2 2025 2.12M $19.52M Add
Q3 2025 1.45M $8.90M Reduce
Q4 2025 1.07M $7.12M Reduce
Q1 2026 2.25M $9.23M Add
Q2 2026 822.43K $5.71M Reduce
Q3 2026 5.09M $40.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EOLS and 13F data

EOLS (EVOLUS INC) is a Health Care company. 21 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$50.0M), BRAIDWELL LP (US$24.7M), Frazier Life Sciences Management, L.P. (US$21.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EOLS

All EOLS fund holders →

FAQ

How long has Soleus Capital Management, L.P. held EOLS?

Soleus Capital Management, L.P. has disclosed EOLS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in EOLS?

As of Q3 2026, Soleus Capital Management, L.P. holds 5.09M shares of EOLS (EVOLUS INC), valued at $40.72M, representing 1.45% of its reported portfolio and ranking #18.

Has Soleus Capital Management, L.P. been buying or selling EOLS?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in EOLS. The position peaked in Q3 2026 at 5.09M shares.

Which other funds hold EOLS?

Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Frazier Life Sciences Management, L.P., among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.